Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial

Dalekos G, Invernizzi P, Nevens F, Hans VV, Zigmond E, Andrade RJ, Ben Ari Z, Heneghan M, Huang J, Harrison S, Minuk G, Joern S, Moreno C, Vierling J, Vincent C, Bowlus C, Lurie Y, Muratori L, Niro G, Hirschfield G, Post A, Zeuzem S, Welzel T, Ch'Ng CL, Levy C, Miller M, Albillos A, Collier JD, Corless L, Dieterich D, Kremer A, Papatheodoridis G, Romeo D, Silveira M, Bernstein D, Cohen-Naftaly M, Floreani A, Borg B, Carey E, Hollywood C, Maliakkal B, Marzioni M, Rabinovitz M, Rupp C, Sheridan D, Stanca C, Swain MG, Veitsman E, Dourakis PS, Wiese P (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: ELSEVIER SCIENCE BV

City/Town: AMSTERDAM

Pages Range: E1-E2

Conference Proceedings Title: JOURNAL OF HEPATOLOGY

Event location: Vienna, AUSTRIA

DOI: 10.1016/s0618-8278(19)30002-7

Authors with CRIS profile

Involved external institutions

University Hospitals of Cleveland / Case Western Reserve University Hospital United States (USA) (US) Gloucestershire Hospitals United Kingdom (GB) Casa Sollievo della Sofferenza Italy (IT) University Hospitals Birmingham NHS Foundation Trust United Kingdom (GB) New York University (NYU) United States (USA) (US) University of Padua / Universita degli Studi di Padova Italy (IT) Southern Therapy and Advanced Research LLC United States (USA) (US) John Buhler Research Center Canada (CA) Ospedaliero Universitaria di Bologna Policlinico S.Orsola-Malpighi Italy (IT) Mayo Clinic in Arizona United States (USA) (US) Rabin Medical Center / מרכז רפואי רבין‎‎ Israel (IL) Methodist Le Bonheur Healthcare United States (USA) (US) General Hospital of Athens Hippocrates / Γενικό Νοσοκομείο Αθηνών «Ιπποκράτειο» Greece (GR) Tel Aviv Sourasky Medical Center / Ichilov Hospital Israel (IL) Pinnacle Clinical Research United States (USA) (US) University Hospitals Plymouth NHS Trust United Kingdom (GB) Houston Texas Medical Center United States (USA) (US) Abertawe Bro Morgannwg University Health Board United Kingdom (GB) University of Thessaly / Πανεπιστήμιο Θεσσαλίας Greece (GR) Università Politecnica delle Marche (UNIVPM) / Marche Polytechnic University Italy (IT) University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven Belgium (BE) University of Calgary Canada (CA) John Radcliffe Hospital United Kingdom (GB) Laikο General Hospital of Athens Greece (GR) University of Pittsburgh United States (USA) (US) University of Milano-Bicocca / Università degli Studi di Milano-Bicocca, UNIMIB Italy (IT) Genkyotex S.A. France (FR) Northwell Health United States (USA) (US) Johannes Gutenberg-Universität Mainz (JGU) Germany (DE) Dayton Gastroenterology, Inc. United States (USA) (US) Icahn School of Medicine at Mount Sinai United States (USA) (US) Hospital Universitario Virgen de la Victoria Spain (ES) University of Miami United States (USA) (US) NHS Tayside United Kingdom (GB) King's College Hospital (KCH) United Kingdom (GB) Goethe-Universität Frankfurt am Main Germany (DE) University of Rochester (UR) United States (USA) (US) Université de Montréal Canada (CA) Yale University United States (USA) (US) Hull and East Yorkshire Hospitals NHS Trust United Kingdom (GB) Hospital Universitario Ramón y Cajal Spain (ES) Universitätsklinikum Heidelberg Germany (DE) Chaim Sheba Medical Center at Tel HaShomer / המרכז הרפואי עש חיים שיבא – תל השומר‎‎ Israel (IL) Hôpital Erasme Belgium (BE) Rambam Health Care Campus Israel (IL) University Hospital Ghent Belgium (BE) University of California Davis (UCDAVIS) United States (USA) (US)

How to cite

APA:

Dalekos, G., Invernizzi, P., Nevens, F., Hans, V.V., Zigmond, E., Andrade, R.J.,... Wiese, P. (2019). Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. In JOURNAL OF HEPATOLOGY (pp. E1-E2). Vienna, AUSTRIA: AMSTERDAM: ELSEVIER SCIENCE BV.

MLA:

Dalekos, George, et al. "Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial." Proceedings of the International Liver Congress, Vienna, AUSTRIA AMSTERDAM: ELSEVIER SCIENCE BV, 2019. E1-E2.

BibTeX: Download